Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation
J Stagg, J Galipeau - Current molecular medicine, 2013 - ingentaconnect.com
Cell therapy with mesenchymal stromal cells (MSCs) is the focus of intensive investigation.
Several clinical trials, including large-scale placebo-controlled phase III clinical trials, are …
Several clinical trials, including large-scale placebo-controlled phase III clinical trials, are …
MSC and tumors: homing, differentiation, and secretion influence therapeutic potential
N D'souza, JS Burns, G Grisendi, O Candini… - … Stem Cells-Basics and …, 2013 - Springer
Mesenchymal stromal/stem cells (MSC) are adult multipotent progenitors with fibroblast-like
morphology able to differentiate into adipocytic, osteogenic, chondrogenic, and myogenic …
morphology able to differentiate into adipocytic, osteogenic, chondrogenic, and myogenic …
Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma
C Yan, S Li, Z Li, H Peng, X Yuan, L Jiang… - Molecular …, 2013 - ACS Publications
Mesenchymal stem cells (MSCs) are an attractive candidate for cell-based therapy. We have
designed a promising double-target therapeutic system for non-Hodgkin's lymphoma (NHL) …
designed a promising double-target therapeutic system for non-Hodgkin's lymphoma (NHL) …
PRAME/EZH2-mediated regulation of TRAIL: a new target for cancer therapy
DD De Carvalho, BP Mello… - Current Molecular …, 2013 - ingentaconnect.com
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) exerts a cancer cell-
specific pro-apoptotic activity. This property made the TRAIL associated pathway one of the …
specific pro-apoptotic activity. This property made the TRAIL associated pathway one of the …
TRAIL-based therapeutic approaches for the treatment of pediatric malignancies
C Gasparini, L Vecchi Brumatti… - Current medicinal …, 2013 - ingentaconnect.com
Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is a pro-apoptotic ligand
that has shown the exquisite ability to trigger extrinsic apoptosis in various types of cancer …
that has shown the exquisite ability to trigger extrinsic apoptosis in various types of cancer …
Mesenchymal stem cells: a revolution in therapeutic strategies of age-related diseases
Y Peng, S Huang, B Cheng, X Nie, J Enhe… - Ageing research …, 2013 - Elsevier
The great evolutionary biologist Theodosius Dobzhansky once said:“Nothing in biology
makes sense except in the light of evolution”. Aging is a complex biological phenomenon …
makes sense except in the light of evolution”. Aging is a complex biological phenomenon …
Genetically Engineered Mesenchymal Stem Cells for Cell and Gene Therapy
Stem cells have enormous potential for regenerative medicine to treat fatal diseases and
injuries that cannot otherwise be healed. In particular, adult stem cell-based therapies have …
injuries that cannot otherwise be healed. In particular, adult stem cell-based therapies have …